Edwards Lifesciences
Headquartered in Irvine, California, Edwards Lifesciences develops medical innovations for structural heart disease, critical care, and surgical monitoring. Its R&D focuses on advanced cardiovascular technologies, including transcatheter and surgical heart valves, heart valve repair systems, and hemodynamic monitoring solutions. The company also researches investigational devices and new treatments for cardiovascular diseases. Edwards Lifesciences collaborates with academic institutions, including the Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center at the University of California, Irvine.
Overview
Featured Content
Transcatheter Heart Valve Replacement
A pioneering project that developed minimally invasive techniques for replacing heart valves without open-heart surgery, leading to the development of the SAPIEN transcatheter heart valve. Shown here is the EVOQUE Valve replacement systemm the first transcatheter vlve to win FDA approval for the tricuspid valve.
Research Areas
Publications per Year
Data for 2024 is incomplete and represents only part of the year.
Patents per Year
Data for 2024 is incomplete and represents only part of the year.